Trichostatin A Promotes Cardiomyocyte Differentiation of Rat Mesenchymal Stem Cells After 5-Azacytidine Induction or During Coculture With Neonatal Cardiomyocytes Via a Mechanism Independent of Histone Deacetylase Inhibition

被引:36
作者
Yang, Ge [1 ]
Tian, Jie [2 ]
Feng, Chuan [1 ]
Zhao, Li-li [1 ]
Liu, Zhenguo [3 ,4 ]
Zhu, Jing [1 ]
机构
[1] Chongqing Med Univ, Inst Pediat, Dept Cell & Mol Biol, Chongqing 400014, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, Dept Cardiol, Chongqing 400014, Peoples R China
[3] Ohio State Univ, Med Ctr, Div Cardiovasc Med, Columbus, OH 43210 USA
[4] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
基金
美国国家科学基金会;
关键词
Mesenchymal stem cells; Cardiac differentiation; Trichostatin A; Histone deacetylase; 5-Azacytidine; Coculture; BONE-MARROW; IN-VITRO; ADULT CARDIOMYOCYTES; STROMAL CELLS; TRANSPLANTATION; THERAPY; ACETYLATION; PLASTICITY; APOPTOSIS; CONTACT;
D O I
10.3727/096368911X593145
中图分类号
Q813 [细胞工程];
学科分类号
摘要
This study was to investigate the effect of trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, on cardiac differentiation of bone marrow mesenchymal stem cells (MSCs) in vitro. Rat MSCs were isolated and divided into six groups: 1) control; 2) 5-azacytidine treatment (5-aza, 10 mu M); 3) treatment with TSA (100, 3(10, and 500 nM); 4) treatment with 5-aza followed by incubation with TSA; 5) coculture with neonatal cardiomyocytes (CMs); and 6) treatment with TSA then coculture with CMs. HDAC activity was significantly inhibited in TSA-treated cells with the maximal inhibition after 24 h of exposure to TSA at 300 nM. No changes in HDAC activity were observed in control, 5-aza-treated, or coculture groups. Following 7 days of differentiation, the expression of early cardiac transcription factors GATA-4, NKx2.5, MEF2c, and cardiac troponin T (cTnT) was increased by 6-8 times in the cells in 5-aza-treated, coculture, or TSA-treated groups over control as determined using real-time PCR, immunofluorescence staining, and Western blotting. However, the percent cTnT-positive cells were dramatically different with 0.7% for control, 10% for 5-aza-treated, 25% for coculture, and 4% for TSA-treated group (500 nM). TSA treatment of the cells pretreated with 5-aza or cocultured with CMs dramatically increased the expression of GATA-4, NKx2.5, and MEF2c by 35-50 times over control. The cTnT protein expression was also significantly increased by over threefold by TSA treatment (500 nM) in both 5-aza-treated and coculture group over control. The percent cTnT-positive cells in both 5-aza-pre-treated and coculture groups were significantly increased by TSA treatment after 1 week of differentiation by up to 92.6% (from 10.3% to 19.8%) and 23.9% (from 24.5% to 30.2%), respectively. These data suggested that TSA enhanced the cardiac differentiation of MSCs after 5-aza induction or (luring coculture with CMs through a mechanism beyond the inhibition of HDAC activity.
引用
收藏
页码:985 / 996
页数:12
相关论文
共 51 条
  • [1] Cross-platform comparison of SYBR® Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study
    Arikawa, Emi
    Sun, Yanyang
    Wang, Jie
    Zhou, Qiong
    Ning, Baitang
    Dial, Stacey L.
    Guo, Lei
    Yang, Jingping
    [J]. BMC GENOMICS, 2008, 9 (1)
  • [2] Cardiac Differentiation Is Driven by NKX2.5 and GATA4 Nuclear Translocation in Tissue-Specific Mesenchymal Stem Cells
    Arminan, Ana
    Gandia, Carolina
    Carmen Bartual, Ma
    Garcia-Verdugo, Jose M.
    Lledo, Elisa
    Mirabet, Vicente
    Llop, Mauro
    Barea, Jose
    Montero, Jose A.
    Sepulveda, Pilar
    [J]. STEM CELLS AND DEVELOPMENT, 2009, 18 (06) : 907 - 917
  • [3] 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells
    Balana, Bartosz
    Nicoletti, Cecilia
    Zahanich, Ihor
    Graf, Eva M.
    Christ, Torsten
    Boxberger, Sabine
    Ravens, Ursula
    [J]. CELL RESEARCH, 2006, 16 (12) : 949 - 960
  • [4] Bascle A., 2003, NUCLEIC ACIDS RES, V31, P6882
  • [5] Mesenchymal stem cells in hematopoietic stem cell transplantation
    Battiwalla, Minoo
    Hematti, Peiman
    [J]. CYTOTHERAPY, 2009, 11 (05) : 503 - 515
  • [6] Burlacu Alexandrina, 2006, Archives of Physiology and Biochemistry, V112, P260, DOI 10.1080/13813450601094631
  • [7] Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: Anatomic basis for functional improvements
    Chedrawy, EG
    Wang, JS
    Nguyen, DM
    Shum-Tim, D
    Chiu, RCJ
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (03) : 584 - 590
  • [8] Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis
    Chen, Jinghai
    Baydoun, Anwar R.
    Xu, Ruixia
    Deng, Linzi
    Liu, Xuebin
    Zhu, Weiquan
    Shi, Linhui
    Cong, Xiangfeng
    Hu, Shengshou
    Chen, Xi
    [J]. STEM CELLS, 2008, 26 (01) : 135 - 145
  • [9] Stem Cell Therapy for Cardiac Repair
    Collins, John M.
    Russell, Brenda
    [J]. JOURNAL OF CARDIOVASCULAR NURSING, 2009, 24 (02) : 93 - 97
  • [10] Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO